Diagnostic Value of Ascitic Fluid Cholesterol Level in Differentiating Malignant Ascites from Non-Malignant Ascites
DOI:
https://doi.org/10.61919/jhrr.v3i2.209Keywords:
Ascites, Cholesterol Levels, Malignancy-Related Ascites, Non-Malignant Ascites, Diagnostic MarkerAbstract
Background: Ascites, the accumulation of fluid in the peritoneal cavity, poses significant diagnostic challenges, particularly in differentiating between malignancy-related ascites (MRA) and non-malignant ascites (NMA). This differentiation is critical for appropriate clinical management.
Objective: The study aimed to evaluate the diagnostic value of ascitic fluid cholesterol levels in distinguishing MRA from NMA.
Methods: This cross-sectional study enrolled 48 patients with ascites, divided equally into Group A (MRA) and Group B (NMA). Diagnostic paracentesis was performed, and 20 ml of ascitic fluid was collected for analysis. Cholesterol levels were measured using the Zaks method. Demographic data were recorded, and statistical analysis was conducted using the Mann-Whitney U-test, with a p-value of 0.05 set for statistical significance.
Results: Both groups had an equal gender distribution (12 males and 12 females in each), and the mean ages were 60.3 ± 19.1 years for Group A and 60.8 ± 17.9 years for Group B. The mean cholesterol level in ascitic fluid was significantly higher in Group B (189.9 ± 29.9 mg%) compared to Group A (167.73 ± 26.87 mg%), with mean standard deviations of 91.8 ± 12.4 and 20.4 ± 9.1, respectively. The p-values for gender distribution and age differences were <0.001.
Conclusion: The study demonstrated that cholesterol levels in ascitic fluid are a reliable biomarker for differentiating between MRA and NMA. Higher cholesterol levels were associated with non-malignant cases, offering a non-invasive, cost-effective diagnostic tool in clinical settings.
Downloads
References
Gallo A, Dedionigi C, Civitelli C, Panzeri A, Corradi C, Squizzato A. Optimal management of cirrhotic ascites: A review for internal medicine physicians. Journal of Translational Internal Medicine. 2020;8(4):220-36.
Biggins SW, Angeli P, Garcia‐Tsao G, Ginès P, Ling SC, Nadim MK, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74(2):1014-48.
Aithal GP, Palaniyappan N, China L, Härmälä S, Macken L, Ryan JM, et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70(1):9-29.
Corning B, Copland AP. Protein-Losing Enteropathy. Essential Medical Disorders of the Stomach and Small Intestine: A Clinical Casebook. 2019:401-15.
Bhaskar K, Devanandan K, Jain JK, Krishna T, Gongati P. Unilateral Transudative Pleural Effusion due to rare Cause-A Case Report. Indian Journal of Cardiovascular Disease in Women-WINCARS. 2022;7(3).
Do TVC, Cozza J, Ganti S, Depa J. Recurrent chylous ascites leading to transudative chylothorax due to bi-ventricular heart failure. Journal of Investigative Medicine High Impact Case Reports. 2021;9:23247096211026144.
Arrington AK. Diseases of the peritoneum, retroperitoneum, mesentery, and omentum. Yamada's Textbook of Gastroenterology. 2022:2135-49.
Chen P-C, Chen B-H, Huang C-H, Jeng W-J, Hsieh Y-C, Teng W, et al. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis. European Journal of Gastroenterology & Hepatology. 2019;31(10):1256-63.
Clemente A, Romero M, Rincón D, Millan J, Bañares R, Martinez RG. ADVANCES IN HEALTH AND DISEASE: PARACENTESIS IN MEDICINE. ADVANCES IN HEALTH AND DISEASE.1.
Chen H, Ishihara M, Horita N, Tanzawa S, Kazahari H, Ochiai R, et al. Effectiveness of cell-free and concentrated ascites reinfusion therapy in the treatment of malignancy-related ascites: a systematic review and meta-analysis. Cancers. 2021;13(19):4873.
Ramamoorthy V, Rubens M, Saxena A, Bhatt C, Das S, Appunni S, et al. Prevalence and inpatient hospital outcomes of malignancy-related ascites in the United States. American Journal of Hospice and Palliative Medicine®. 2021;38(1):47-53.
Jackson K, Frew K, Johnston R, Coleman J, Armstrong L, Aujayeb A, editors. Indwelling Peritoneal Catheter for Ascites Management in a UK District General Hospital: A Cohort Study. Healthcare; 2021: MDPI.
Priyadarshi B, Singh M, Verma AK, Midha T. To Study the Usefulness of Serum and Ascitic Fluid C-Reactive Protein (Crp) and Ascitic Fluid Cholesterol Level in Differential Diagnosis of Malignant, Nonmalignant and Tubercular Ascites. Journal of Evolution of Medical and Dental Sciences. 2018;7(9):1126-30.
PASHA MK, KuMaR BR, MacheRla R, REDDY SL, PANI SK, AYESHA Q, et al. Biochemical Markers of Ascitic Fluid to Differentiate Ovarian Cancer from Liver Cirrhosis Patients. Journal of Clinical & Diagnostic Research. 2020;14(6).
Mahajan M, Prasad ML, Kumar P, Kumar A, Chatterjee N, Singh S, et al. An Updated Systematic Review and Meta-Analysis for the Diagnostic Test Accuracy of Ascitic Fluid Adenosine Deaminase in Tuberculous Peritonitis. Infection & Chemotherapy. 2023;55(2):264.
Karnsakul W, Wasuwanich P, Ingviya T, Laengvejkal P, Vasilescu A, Imteyaz H, et al. Clinical usage of serum albumin to ascitic fluid albumin gradient and ascitic fluid total protein in pediatric ascites. Clinics and Research in Hepatology and Gastroenterology. 2021;45(3):101549.
Sharma V, Sharma R, Arora P, Goyal N, Sharma S. Study of Cholesterol Levels in Ascitic Fluid to Differentiate Malignant from Non-Malignant Effusion. Journal of Evolution of Medical and Dental Sciences. 2020;9(26):1903-8.
Soren T, DaS T, Behera BP, Sahu D, SIngh SC. Comparison of Ascitic Fluid Cholesterol and Fibronectin with Conventional Ascitic Protein Values in Differentiating Malignant Ascites from Non malignant Ascites: A Cross-sectional Study. Journal of Clinical & Diagnostic Research. 2023;17(11).
Zaccherini G, Tufoni M, Iannone G, Caraceni P. Management of ascites in patients with cirrhosis: An update. Journal of Clinical Medicine. 2021;10(22):5226.
Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Advances in cancer research. 2021;149:1-61.
Konyn P, Ahmed A, Kim D. Current epidemiology in hepatocellular carcinoma. Expert review of gastroenterology & hepatology. 2021;15(11):1295-307.
Guo Y-Y, Peng X-L, Zhan N, Tian S, Li J, Dong W-G. Development and validation a simple model for identify malignant ascites. International Journal of Medical Sciences. 2021;18(9):1966.
Sangiovanni A, Alimenti E, Gattai R, Filomia R, Parente E, Valenti L, et al. Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis. Journal of hepatology. 2020;73(3):593-602.
Abdelbaset A, Jouda A, Pasha H, Soliman A, Toam M, Elkhashab M. Value of ascitic fluid lipids in the differentiation between cirrhotic and malignant ascites. Clinical Cancer Investigation Journal. 2019;8(5).
Prabhu M, Gangula RS, Stanley W. Diagnostic utility of serum ascites lipid and protein gradients in differentiation of ascites. International Journal of Hepatology. 2019;2019.
Hussain SA, Uppal S, Mahajan S, Sood N. Reticular diaphragmatic hernia in water buffalo: clinical characteristics, haematology, biochemical analytes, and prognostic indicators. Comparative Clinical Pathology. 2021;30(4):605-15.
Ozer N, Sozutek A, Sahin A, Seker A, Genc IC, Yugruk A. The Role of Ca 19-9, Ca 72-4, Cea and Cholesterol Levels in Predicting Malignancy in Gallbladder Polyps. Journal of the College of Physicians and Surgeons--Pakistan: JCPSP. 2021;31(12):1422-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Bilal Rasheed, Muhammad Imran, Rabia Parveen, Arosha Mansoora Khan, Faryal Riaz Khan, Aqsa Tassadduq, Maria Ahmed, Muhammad Farrukh Habib
This work is licensed under a Creative Commons Attribution 4.0 International License.
